Literature DB >> 19261378

Resveratrol and chemoprevention.

Shyamal K Goswami1, Dipak K Das.   

Abstract

Resveratrol is a phytoalexin, highly abundant in skins of red grapes and moderately abundant in peanuts and blueberries. Originally a constituent of oriental medicines, it has lately been rediscovered for a plethora of beneficial properties such as anti-cancer, anti-aging, antiviral, cardiovascular and neuroprotective effects, thereby making it one of the most sought after phytochemicals for supplementing human diet. Studies done in various laboratories have shown its modulatory effects on multitudes of cell signaling and gene expression pathways. Although most of its effects have been observed in cultured cells, quite a few have also been validated in whole animals as well. It is thus necessary to have a comprehensive look at all those effects of resveratrol in an organismal context. The following review summarizes the effects of resveratrol in the context of chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19261378     DOI: 10.1016/j.canlet.2009.01.041

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  43 in total

1.  Wine drinking and epithelial ovarian cancer risk: a meta-analysis.

Authors:  Hee Seung Kim; Jae Weon Kim; Leo J Shouten; Susanna C Larsson; Hyun Hoon Chung; Yong Beom Kim; Woong Ju; Noh Hyun Park; Yong Sang Song; Seung Cheol Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis.

Authors:  Jung H Back; Yucui Zhu; Alyssa Calabro; Craig Queenan; Audrey S Kim; Joshua Arbesman; Arianna L Kim
Journal:  Photochem Photobiol       Date:  2012-02-17       Impact factor: 3.421

Review 3.  Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

Authors:  Tze-chen Hsieh; Joseph M Wu
Journal:  Biofactors       Date:  2010 Sep-Oct       Impact factor: 6.113

4.  Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease.

Authors:  Kinan Rahal; Phyllissa Schmiedlin-Ren; Jeremy Adler; Muhammad Dhanani; Victoria Sultani; Ahren C Rittershaus; Laura Reingold; Ji Zhu; Barbara J McKenna; Gregory M Christman; Ellen M Zimmermann
Journal:  Inflamm Bowel Dis       Date:  2011-08-29       Impact factor: 5.325

5.  Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet.

Authors:  M T Macarulla; G Alberdi; S Gómez; I Tueros; C Bald; V M Rodríguez; J A Martínez; M P Portillo
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

6.  Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study.

Authors:  Darren R Brenner; Gord Fehringer; Zuo-Feng Zhang; Yuan-Chin Amy Lee; Travis Meyers; Keitaro Matsuo; Hidemi Ito; Paolo Vineis; Isabelle Stucker; Paolo Boffetta; Paul Brennan; David C Christiani; Nancy Diao; Yun-Chul Hong; Maria T Landi; Hal Morgenstern; Ann G Schwartz; Gad Rennert; Walid Saliba; John R McLaughlin; Curtis C Harris; Irene Orlow; Juan M Barros Dios; Alberto Ruano Raviña; Jack Siemiatycki; Anita Koushik; Michele Cote; Philip Lazarus; Guillermo Fernandez-Tardon; Adonina Tardon; Loïc Le Marchand; Hermann Brenner; Kai-Uwe Saum; Eric J Duell; Angeline S Andrew; Dario Consonni; Ann Olsson; Rayjean J Hung; Kurt Straif
Journal:  Cancer Epidemiol       Date:  2018-11-13       Impact factor: 2.984

Review 7.  MicroRNA signatures of resveratrol in the ischemic heart.

Authors:  Partha Mukhopadhyay; Pal Pacher; Dipak K Das
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

8.  Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.

Authors:  Izet M Kapetanovic; Miguel Muzzio; Zhihua Huang; Thomas N Thompson; David L McCormick
Journal:  Cancer Chemother Pharmacol       Date:  2010-11-30       Impact factor: 3.333

9.  TRPC5 channel sensitivities to antioxidants and hydroxylated stilbenes.

Authors:  Jacqueline Naylor; Eman Al-Shawaf; Lynn McKeown; Paul T Manna; Karen E Porter; David O'Regan; Katsuhiko Muraki; David J Beech
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 10.  Helicobacter pylori and interleukin-8 in gastric cancer.

Authors:  Ko Eun Lee; Pham Ngoc Khoi; Yong Xia; Jung Sun Park; Young Eun Joo; Kyung Keun Kim; Seok Yong Choi; Young Do Jung
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.